Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Oct;79(10):953–960. doi: 10.1136/bjo.79.10.953

Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

D G Charteris 1
PMCID: PMC505299  PMID: 7488586

Full text

PDF
953

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand R., Nightingale S. D., Fish R. H., Smith T. J., Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol. 1993 Feb;111(2):223–227. doi: 10.1001/archopht.1993.01090020077027. [DOI] [PubMed] [Google Scholar]
  2. Andenmatten R., Gonvers M. Sophisticated vitreoretinal surgery in patients with a healthy fellow eye. An 11-year retrospective study. Graefes Arch Clin Exp Ophthalmol. 1993 Sep;231(9):495–499. doi: 10.1007/BF00921113. [DOI] [PubMed] [Google Scholar]
  3. Araiz J. J., Refojo M. F., Arroyo M. H., Leong F. L., Albert D. M., Tolentino F. I. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1993 Mar;34(3):522–530. [PubMed] [Google Scholar]
  4. Arroyo M. H., Refojo M. F., Araiz J. J., Tolentino F. I., Cajita V. N., Elner V. M. Silicone oil as a delivery vehicle for BCNU in rabbit proliferative vitreoretinopathy. Retina. 1993;13(3):245–250. doi: 10.1097/00006982-199313030-00011. [DOI] [PubMed] [Google Scholar]
  5. Barrada A., Peyman G. A., Greenberg D., Stelmack T., Fiscella R. Toxicity of antineoplastic drugs in vitrectomy infusion fluids. Ophthalmic Surg. 1983 Oct;14(10):845–847. [PubMed] [Google Scholar]
  6. Baudouin C., Fredj-Reygrobellet D., Baudouin F., Lapalus P., Gastaud P. Immunohistologic study of proliferative vitreoretinopathy. Am J Ophthalmol. 1989 Oct 15;108(4):387–394. doi: 10.1016/s0002-9394(14)73306-9. [DOI] [PubMed] [Google Scholar]
  7. Baudouin C., Fredj-Reygrobellet D., Brignole F., Nègre F., Lapalus P., Gastaud P. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res. 1993;25(1):52–59. doi: 10.1159/000267221. [DOI] [PubMed] [Google Scholar]
  8. Baudouin C., Fredj-Reygrobellet D., Gordon W. C., Baudouin F., Peyman G., Lapalus P., Gastaud P., Bazan N. G. Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy. Am J Ophthalmol. 1990 Dec 15;110(6):593–598. doi: 10.1016/s0002-9394(14)77054-0. [DOI] [PubMed] [Google Scholar]
  9. Berman D. H., Gombos G. M. Proliferative vitreoretinopathy: does oral low-dose colchicine have an inhibitory effect? A controlled study in humans. Ophthalmic Surg. 1989 Apr;20(4):268–272. [PubMed] [Google Scholar]
  10. Binder S., Bonnet M., Velikay M., Gerard J. P., Stolba U., Wedrich A., Hohenberg H. Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study. Graefes Arch Clin Exp Ophthalmol. 1994 Apr;232(4):211–214. doi: 10.1007/BF00184007. [DOI] [PubMed] [Google Scholar]
  11. Blankenship G. W. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Graefes Arch Clin Exp Ophthalmol. 1989;227(6):565–568. doi: 10.1007/BF02169453. [DOI] [PubMed] [Google Scholar]
  12. Blumenkranz M. S., Azen S. P., Aaberg T., Boone D. C., Lewis H., Radtke N., Ryan S. J. Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5. The Silicone Study Group. Am J Ophthalmol. 1993 Nov 15;116(5):557–564. doi: 10.1016/s0002-9394(14)73196-4. [DOI] [PubMed] [Google Scholar]
  13. Blumenkranz M. S., Claflin A., Hajek A. S. Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol. 1984 Apr;102(4):598–604. doi: 10.1001/archopht.1984.01040030470029. [DOI] [PubMed] [Google Scholar]
  14. Blumenkranz M. S., Ophir A., Claflin A. J., Hajek A. Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol. 1982 Oct;94(4):458–467. doi: 10.1016/0002-9394(82)90239-2. [DOI] [PubMed] [Google Scholar]
  15. Blumenkranz M., Hernandez E., Ophir A., Norton E. W. 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology. 1984 Feb;91(2):122–130. doi: 10.1016/s0161-6420(84)34318-4. [DOI] [PubMed] [Google Scholar]
  16. Bresgen M., Martiny B., Weller M., Heimann K., Wiedemann P. Analyse des Proteinmusters in physiologischen und pathologischen Glaskörpern durch Elektrophorese und immunologische Identifizierung. Fortschr Ophthalmol. 1991;88(6):665–670. [PubMed] [Google Scholar]
  17. Brinkman C. J., Broekhuyse R. M. Cell-mediated immunity after retinal detachment as determined by lymphocyte stimulation. Am J Ophthalmol. 1978 Aug;86(2):260–265. doi: 10.1016/s0002-9394(14)76822-9. [DOI] [PubMed] [Google Scholar]
  18. Broekhuyse R. M., Rademakers A. J., Van Vugt A. H., Winkens H. J. Autoimmune responsiveness to retinal IRBP, S-antigen and opsin in proliferative vitreoretinopathy. Exp Eye Res. 1990 Feb;50(2):197–202. doi: 10.1016/0014-4835(90)90231-i. [DOI] [PubMed] [Google Scholar]
  19. Campochiaro P. A., Bryan J. A., 3rd, Conway B. P., Jaccoma E. H. Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown. Arch Ophthalmol. 1986 Nov;104(11):1685–1687. doi: 10.1001/archopht.1986.01050230123046. [DOI] [PubMed] [Google Scholar]
  20. Campochiaro P. A., Glaser B. M. Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch Ophthalmol. 1985 Apr;103(4):576–579. doi: 10.1001/archopht.1985.01050040118034. [DOI] [PubMed] [Google Scholar]
  21. Campochiaro P. A., Hackett S. F., Conway B. P. Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1991 Jan;32(1):65–72. [PubMed] [Google Scholar]
  22. Campochiaro P. A., Kaden I. H., Vidaurri-Leal J., Glaser B. M. Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol. 1985 Mar;103(3):434–436. doi: 10.1001/archopht.1985.01050030130038. [DOI] [PubMed] [Google Scholar]
  23. Chandler D. B., Hida T., Sheta S., Proia A. D., Machemer R. Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment. Graefes Arch Clin Exp Ophthalmol. 1987;225(4):259–265. doi: 10.1007/BF02150144. [DOI] [PubMed] [Google Scholar]
  24. Chang S., Ozmert E., Zimmerman N. J. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol. 1988 Dec 15;106(6):668–674. doi: 10.1016/0002-9394(88)90698-8. [DOI] [PubMed] [Google Scholar]
  25. Charteris D. G., Hiscott P., Grierson I., Lightman S. L. Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Ophthalmology. 1992 Sep;99(9):1364–1367. doi: 10.1016/s0161-6420(92)31793-2. [DOI] [PubMed] [Google Scholar]
  26. Charteris D. G., Hiscott P., Robey H. L., Gregor Z. J., Lightman S. L., Grierson I. Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology. 1993 Jan;100(1):43–46. doi: 10.1016/s0161-6420(93)31711-2. [DOI] [PubMed] [Google Scholar]
  27. Chen J. C., Robertson J. E., Coonan P., Blodi C. F., Klein M. L., Watzke R. C., Folk J. C., Weingeist T. A. Results and complications of pneumatic retinopexy. Ophthalmology. 1988 May;95(5):601–606. doi: 10.1016/s0161-6420(88)33134-9. [DOI] [PubMed] [Google Scholar]
  28. Chignell A. H., Fison L. G., Davies E. W., Hartley R. E., Gundry M. F. Failure in retinal detachment surgery. Br J Ophthalmol. 1973 Aug;57(8):525–530. doi: 10.1136/bjo.57.8.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Clarkson J. G., Green W. R., Massof D. A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol. 1977 Jul;84(1):1–17. [PubMed] [Google Scholar]
  30. Cowley M., Conway B. P., Campochiaro P. A., Kaiser D., Gaskin H. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol. 1989 Aug;107(8):1147–1151. doi: 10.1001/archopht.1989.01070020213027. [DOI] [PubMed] [Google Scholar]
  31. Czaja M. J., Weiner F. R., Eghbali M., Giambrone M. A., Eghbali M., Zern M. A. Differential effects of gamma-interferon on collagen and fibronectin gene expression. J Biol Chem. 1987 Sep 25;262(27):13348–13351. [PubMed] [Google Scholar]
  32. Daniels S. A., Coonley K. G., Yoshizumi M. O. Taxol treatment of experimental proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1990;228(6):513–516. doi: 10.1007/BF00918482. [DOI] [PubMed] [Google Scholar]
  33. Doekes G., van der Gaag R., Rothova A., van Kooyk Y., Broersma L., Zaal M. J., Dijkman G., Fortuin M. E., Baarsma G. S., Kijlstra A. Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res. 1987 Jul;6(7):909–919. doi: 10.3109/02713688709034859. [DOI] [PubMed] [Google Scholar]
  34. Esser P., Heimann K., Wiedemann P. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol. 1993 Nov;77(11):731–733. doi: 10.1136/bjo.77.11.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Fastenberg D. M., Diddie K. R., Delmage J. M., Dorey K. Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy. Am J Ophthalmol. 1983 May;95(5):663–667. doi: 10.1016/0002-9394(83)90387-2. [DOI] [PubMed] [Google Scholar]
  36. Federman J. L., Eagle R. C., Jr Extensive peripheral retinectomy combined with posterior 360 degrees retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy cases. Ophthalmology. 1990 Oct;97(10):1305–1320. doi: 10.1016/s0161-6420(90)32416-8. [DOI] [PubMed] [Google Scholar]
  37. Federman J. L., Schubert H. D. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology. 1988 Jul;95(7):870–876. doi: 10.1016/s0161-6420(88)33080-0. [DOI] [PubMed] [Google Scholar]
  38. Foos R. Y. Vitreoretinal juncture--simple epiretinal membranes. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1974 Jan 28;189(4):231–250. doi: 10.1007/BF02384852. [DOI] [PubMed] [Google Scholar]
  39. Forrester J. V., Stott D. I., Hercus K. M. Naturally occurring antibodies to bovine and human retinal S antigen: a comparison between uveitis patients and healthy volunteers. Br J Ophthalmol. 1989 Feb;73(2):155–159. doi: 10.1136/bjo.73.2.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Froebel K. S., Armstrong S. S., Cliffe A. M., Urbaniak S. J., Forrester J. V. An investigation of the general immune status and specific immune responsiveness to retinal-(S)-antigen in patients with chronic posterior uveitis. Eye (Lond) 1989;3(Pt 3):263–270. doi: 10.1038/eye.1989.36. [DOI] [PubMed] [Google Scholar]
  41. Gilbert C., McLeod D. D-ACE surgical sequence for selected bullous retinal detachments. Br J Ophthalmol. 1985 Oct;69(10):733–736. doi: 10.1136/bjo.69.10.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Giordano G. G., Refojo M. F., Arroyo M. H. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Invest Ophthalmol Vis Sci. 1993 Aug;34(9):2743–2751. [PubMed] [Google Scholar]
  43. Glaser B. M., Cardin A., Biscoe B. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology. 1987 Apr;94(4):327–332. doi: 10.1016/s0161-6420(87)33443-8. [DOI] [PubMed] [Google Scholar]
  44. Glaser B. M., Vidaurri-Leal J., Michels R. G., Campochiaro P. A. Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology. 1993 Apr;100(4):466–470. doi: 10.1016/s0161-6420(93)31620-9. [DOI] [PubMed] [Google Scholar]
  45. Gonvers M., Thresher R. Temporary use of silicone oil in the treatment of proliferative vitreoretinopathy. An experimental study with a new animal model. Graefes Arch Clin Exp Ophthalmol. 1983;221(1):46–53. doi: 10.1007/BF02171731. [DOI] [PubMed] [Google Scholar]
  46. Griffiths P. G., Richardson J. Causes of proliferative retinopathy following pneumatic retinopexy. Arch Ophthalmol. 1990 Nov;108(11):1515–1515. doi: 10.1001/archopht.1990.01070130017003. [DOI] [PubMed] [Google Scholar]
  47. Grisanti S., Heimann K., Wiedemann P. Immune response to specific molecules of the retina in proliferative vitreoretinal disorders. Graefes Arch Clin Exp Ophthalmol. 1994 May;232(5):302–307. doi: 10.1007/BF00194480. [DOI] [PubMed] [Google Scholar]
  48. Grisanti S., Wiedemann P., Weller M., Heimann K., Zilles K. The significance of complement in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1991 Sep;32(10):2711–2717. [PubMed] [Google Scholar]
  49. Han D. P., Rychwalski P. J., Mieler W. F., Abrams G. W. Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection. Am J Ophthalmol. 1994 Jul 15;118(1):24–32. doi: 10.1016/s0002-9394(14)72838-7. [DOI] [PubMed] [Google Scholar]
  50. Hanneken A. M., Michels R. G. Vitrectomy and scleral buckling methods for proliferative vitreoretinopathy. Ophthalmology. 1988 Jul;95(7):865–869. doi: 10.1016/s0161-6420(88)33081-2. [DOI] [PubMed] [Google Scholar]
  51. Harvey A. K., Roberge F., Hjelmeland L. M. Chemotaxis of rat retinal glia to growth factors found in repairing wounds. Invest Ophthalmol Vis Sci. 1987 Jul;28(7):1092–1099. [PubMed] [Google Scholar]
  52. Hashizoe M., Ogura Y., Kimura H., Moritera T., Honda Y., Kyo M., Hyon S. H., Ikada Y. Scleral plug of biodegradable polymers for controlled drug release in the vitreous. Arch Ophthalmol. 1994 Oct;112(10):1380–1384. doi: 10.1001/archopht.1994.01090220130035. [DOI] [PubMed] [Google Scholar]
  53. Heidenkummer H. P., Kampik A. Intercellular adhesion molecule-1 (ICAM-1) and leukocyte function-associated antigen-1 (LFA-1) expression in human epiretinal membranes. Graefes Arch Clin Exp Ophthalmol. 1992;230(5):483–487. doi: 10.1007/BF00175938. [DOI] [PubMed] [Google Scholar]
  54. Hiscott P. S., Grierson I., McLeod D. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol. 1985 Nov;69(11):810–823. doi: 10.1136/bjo.69.11.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Hiscott P. S., Grierson I., McLeod D. Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br J Ophthalmol. 1984 Oct;68(10):708–715. doi: 10.1136/bjo.68.10.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hiscott P. S., Grierson I., Trombetta C. J., Rahi A. H., Marshall J., McLeod D. Retinal and epiretinal glia--an immunohistochemical study. Br J Ophthalmol. 1984 Oct;68(10):698–707. doi: 10.1136/bjo.68.10.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Hiscott P., Grierson I. Subretinal membranes of proliferative vitreoretinopathy. Br J Ophthalmol. 1991 Jan;75(1):53–53. doi: 10.1136/bjo.75.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Hiscott P., Morino I., Alexander R., Grierson I., Gregor Z. Cellular components of subretinal membranes in proliferative vitreoretinopathy. Eye (Lond) 1989;3(Pt 5):606–610. doi: 10.1038/eye.1989.94. [DOI] [PubMed] [Google Scholar]
  59. Hiscott P., Waller H. A., Grierson I., Butler M. G., Scott D. Local production of fibronectin by ectopic human retinal cells. Cell Tissue Res. 1992 Jan;267(1):185–192. doi: 10.1007/BF00318703. [DOI] [PubMed] [Google Scholar]
  60. Hutton W. L., Azen S. P., Blumenkranz M. S., Lai M. Y., McCuen B. W., Han D. P., Flynn H. W., Jr, Ramsay R. C., Ryan S. J. The effects of silicone oil removal. Silicone Study Report 6. Arch Ophthalmol. 1994 Jun;112(6):778–785. doi: 10.1001/archopht.1994.01090180076038. [DOI] [PubMed] [Google Scholar]
  61. Ignotz R. A., Massagué J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986 Mar 25;261(9):4337–4345. [PubMed] [Google Scholar]
  62. Jaccoma E. H., Conway B. P., Campochiaro P. A. Cryotherapy causes extensive breakdown of the blood-retinal barrier. A comparison with argon laser photocoagulation. Arch Ophthalmol. 1985 Nov;103(11):1728–1730. doi: 10.1001/archopht.1985.01050110124039. [DOI] [PubMed] [Google Scholar]
  63. Jaffe G. J., Earnest K., Fulcher S., Lui G. M., Houston L. L. Antitransferrin receptor immunotoxin inhibits proliferating human retinal pigment epithelial cells. Arch Ophthalmol. 1990 Aug;108(8):1163–1168. doi: 10.1001/archopht.1990.01070100119046. [DOI] [PubMed] [Google Scholar]
  64. Jaffe G. J., Schwartz D., Han D. P., Gottlieb M., Hartz A., McCarty D., Mieler W. F., Abrams G. W. Risk factors for postvitrectomy fibrin formation. Am J Ophthalmol. 1990 Jun 15;109(6):661–667. doi: 10.1016/s0002-9394(14)72434-1. [DOI] [PubMed] [Google Scholar]
  65. Jerdan J. A., Pepose J. S., Michels R. G., Hayashi H., de Bustros S., Sebag M., Glaser B. M. Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology. 1989 Jun;96(6):801–810. doi: 10.1016/s0161-6420(89)32818-1. [DOI] [PubMed] [Google Scholar]
  66. Johnson R. N., Blankenship G. A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin. Ophthalmology. 1988 Mar;95(3):312–317. doi: 10.1016/s0161-6420(88)33181-7. [DOI] [PubMed] [Google Scholar]
  67. Kampik A., Kenyon K. R., Michels R. G., Green W. R., de la Cruz Z. C. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol. 1981 Aug;99(8):1445–1454. doi: 10.1001/archopht.1981.03930020319025. [DOI] [PubMed] [Google Scholar]
  68. Khawly J. A., Saloupis P., Hatchell D. L., Machemer R. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1991;229(5):464–467. doi: 10.1007/BF00166311. [DOI] [PubMed] [Google Scholar]
  69. Kim R. Y., Stern W. H. Retinoids and butyrate modulate fibroblast growth and contraction of collagen matrices. Invest Ophthalmol Vis Sci. 1990 Jun;31(6):1183–1186. [PubMed] [Google Scholar]
  70. Koerner F., Merz A., Gloor B., Wagner E. Postoperative retinal fibrosis--a controlled clinical study of systemic steroid therapy. Graefes Arch Clin Exp Ophthalmol. 1982;219(6):268–271. doi: 10.1007/BF00231411. [DOI] [PubMed] [Google Scholar]
  71. Kovacs E. J., Kelley J. Lymphokine regulation of macrophage-derived growth factor secretion following pulmonary injury. Am J Pathol. 1985 Nov;121(2):261–268. [PMC free article] [PubMed] [Google Scholar]
  72. Kuriyama S., Ohuchi T., Yoshimura N., Honda Y., Hiraoka M., Abe M. Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits. Graefes Arch Clin Exp Ophthalmol. 1990;228(6):552–555. doi: 10.1007/BF00918489. [DOI] [PubMed] [Google Scholar]
  73. Lambrou F. H., Burke J. M., Aaberg T. M. Effect of silicone oil on experimental traction retinal detachment. Arch Ophthalmol. 1987 Sep;105(9):1269–1272. doi: 10.1001/archopht.1987.01060090127042. [DOI] [PubMed] [Google Scholar]
  74. Lean J. S., van der Zee W. A., Ryan S. J. Experimental model of proliferative vitreoretinopathy (PVR) in the vitrectomised eye: effect of silicone oil. Br J Ophthalmol. 1984 May;68(5):332–335. doi: 10.1136/bjo.68.5.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Leaver P. K., Grey R. H., Garner A. Silicone oil injection in the treatment of massive preretinal retraction. II. Late complications in 93 eyes. Br J Ophthalmol. 1979 May;63(5):361–367. doi: 10.1136/bjo.63.5.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Lemor M., Yeo J. H., Glaser B. M. Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol. 1986 Aug;104(8):1226–1229. doi: 10.1001/archopht.1986.01050200132067. [DOI] [PubMed] [Google Scholar]
  77. Lemor M., de Bustros S., Glaser B. M. Low-dose colchicine inhibits astrocyte, fibroblast, and retinal pigment epithelial cell migration and proliferation. Arch Ophthalmol. 1986 Aug;104(8):1223–1225. doi: 10.1001/archopht.1986.01050200129066. [DOI] [PubMed] [Google Scholar]
  78. Leschey K. H., Hackett S. F., Singer J. H., Campochiaro P. A. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990 May;31(5):839–846. [PubMed] [Google Scholar]
  79. Leschey K. H., Hines J., Singer J. H., Hackett S. F., Campochiaro P. A. Inhibition of growth factor effects in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1991 May;32(6):1770–1778. [PubMed] [Google Scholar]
  80. Lewis H., Aaberg T. M., Abrams G. W. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol. 1991 Jan 15;111(1):8–14. doi: 10.1016/s0002-9394(14)76889-8. [DOI] [PubMed] [Google Scholar]
  81. Lewis H., Aaberg T. M. Anterior proliferative vitreoretinopathy. Am J Ophthalmol. 1988 Mar 15;105(3):277–284. doi: 10.1016/0002-9394(88)90010-4. [DOI] [PubMed] [Google Scholar]
  82. Lewis H., Aaberg T. M. Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. Am J Ophthalmol. 1991 Jan 15;111(1):15–19. doi: 10.1016/s0002-9394(14)76890-4. [DOI] [PubMed] [Google Scholar]
  83. Lewis H., Burke J. M., Abrams G. W., Aaberg T. M. Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy. Ophthalmology. 1988 May;95(5):583–591. doi: 10.1016/s0161-6420(88)33136-2. [DOI] [PubMed] [Google Scholar]
  84. Limb G. A., Earley O., Jones S. E., LeRoy F., Chignell A. H., Dumonde D. C. Expression of mRNA coding for TNF alpha, IL-1 beta and IL-6 by cells infiltrating retinal membranes. Graefes Arch Clin Exp Ophthalmol. 1994 Nov;232(11):646–651. doi: 10.1007/BF00171378. [DOI] [PubMed] [Google Scholar]
  85. Limb G. A., Franks W. A., Munasinghe K. R., Chignell A. H., Dumonde D. C. Proliferative vitreoretinopathy: an examination of the involvement of lymphocytes, adhesion molecules and HLA-DR antigens. Graefes Arch Clin Exp Ophthalmol. 1993 Jun;231(6):331–336. doi: 10.1007/BF00919029. [DOI] [PubMed] [Google Scholar]
  86. Limb G. A., Little B. C., Meager A., Ogilvie J. A., Wolstencroft R. A., Franks W. A., Chignell A. H., Dumonde D. C. Cytokines in proliferative vitreoretinopathy. Eye (Lond) 1991;5(Pt 6):686–693. doi: 10.1038/eye.1991.126. [DOI] [PubMed] [Google Scholar]
  87. Liversidge J., Sewell H. F., Forrester J. V. Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology. 1990 Nov;71(3):390–396. [PMC free article] [PubMed] [Google Scholar]
  88. Machemer R., Aaberg T. M., Freeman H. M., Irvine A. R., Lean J. S., Michels R. M. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991 Aug 15;112(2):159–165. doi: 10.1016/s0002-9394(14)76695-4. [DOI] [PubMed] [Google Scholar]
  89. Machemer R., Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975 Jul;80(1):1–23. doi: 10.1016/0002-9394(75)90862-4. [DOI] [PubMed] [Google Scholar]
  90. Machemer R. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture. Invest Ophthalmol Vis Sci. 1988 Dec;29(12):1771–1783. [PubMed] [Google Scholar]
  91. Machemer R. Surgical approaches to subretinal strands. Am J Ophthalmol. 1980 Jul;90(1):81–85. doi: 10.1016/s0002-9394(14)75080-9. [DOI] [PubMed] [Google Scholar]
  92. Machemer R., van Horn D., Aaberg T. M. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978 Feb;85(2):181–191. doi: 10.1016/s0002-9394(14)75946-x. [DOI] [PubMed] [Google Scholar]
  93. Maguire A. M., Smiddy W. E., Nanda S. K., Michels R. G., de la Cruz Z., Green W. R. Clinicopathologic correlation of recurrent epiretinal membranes after previous surgical removal. Retina. 1990;10(3):213–222. [PubMed] [Google Scholar]
  94. Malecaze F., Mathis A., Arné J. L., Raulais D., Courtois Y., Hicks D. Localization of acidic fibroblast growth factor in proliferative vitreoretinopathy membranes. Curr Eye Res. 1991 Aug;10(8):719–729. doi: 10.3109/02713689109013866. [DOI] [PubMed] [Google Scholar]
  95. Mandelcorn M. S., Machemer R., Fineberg E., Hersch S. B. Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants. Am J Ophthalmol. 1975 Aug;80(2):227–237. doi: 10.1016/0002-9394(75)90137-3. [DOI] [PubMed] [Google Scholar]
  96. Martin D. F., Parks D. J., Mellow S. D., Ferris F. L., Walton R. C., Remaley N. A., Chew E. Y., Ashton P., Davis M. D., Nussenblatt R. B. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol. 1994 Dec;112(12):1531–1539. doi: 10.1001/archopht.1994.01090240037023. [DOI] [PubMed] [Google Scholar]
  97. Mazure A., Grierson I. In vitro studies of the contractility of cell types involved in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1992 Nov;33(12):3407–3416. [PubMed] [Google Scholar]
  98. McCormack P., Simcock P. R., Charteris D., Lavin M. J. Is surgery for proliferative vitreoretinopathy justifiable? Eye (Lond) 1994;8(Pt 1):75–76. doi: 10.1038/eye.1994.14. [DOI] [PubMed] [Google Scholar]
  99. Melin M., Hartmann D. J., Magloire H., Falcoff E., Auriault C., Grimaud J. A. Human recombinant gamma-interferon stimulates proliferation and inhibits collagen and fibronectin production by human dental pulp fibroblasts. Cell Mol Biol. 1989;35(1):97–110. [PubMed] [Google Scholar]
  100. Michels R. G. Surgery of retinal detachment with proliferative vitreoretinopathy. Retina. 1984 Spring-Summer;4(2):63–83. doi: 10.1097/00006982-198400420-00001. [DOI] [PubMed] [Google Scholar]
  101. Molnar M. L., Stefansson K., Molnar G. K., Tripathi R. C., Marton L. S. Species variations in distribution of S100 in retina. Demonstration with a monoclonal antibody and a polyclonal antiserum. Invest Ophthalmol Vis Sci. 1985 Mar;26(3):283–288. [PubMed] [Google Scholar]
  102. Morino I., Hiscott P., McKechnie N., Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br J Ophthalmol. 1990 Jul;74(7):393–399. doi: 10.1136/bjo.74.7.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Mueller-Jensen K., Machemer R., Azarnia R. Autotransplantation of retinal pigment epithelium in intravitreal diffusion chamber. Am J Ophthalmol. 1975 Sep;80(3 Pt 2):530–537. doi: 10.1016/0002-9394(75)90222-6. [DOI] [PubMed] [Google Scholar]
  104. Ohuchi T., Kuriyama S., Yoshimura N., Honda Y., Hiraoka M., Abe M. The effect of X-ray irradiation on human retinal pigment epithelial cell proliferation. Graefes Arch Clin Exp Ophthalmol. 1991;229(1):75–78. doi: 10.1007/BF00172266. [DOI] [PubMed] [Google Scholar]
  105. Peyman G. A., Schulman J. Proliferative vitreoretinopathy and chemotherapeutic agents. Surv Ophthalmol. 1985 May-Jun;29(6):434–442. doi: 10.1016/0039-6257(85)90208-5. [DOI] [PubMed] [Google Scholar]
  106. Piguet P. F., Collart M. A., Grau G. E., Sappino A. P., Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature. 1990 Mar 15;344(6263):245–247. doi: 10.1038/344245a0. [DOI] [PubMed] [Google Scholar]
  107. Postlethwaite A. E., Raghow R., Stricklin G. P., Poppleton H., Seyer J. M., Kang A. H. Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol. 1988 Feb;106(2):311–318. doi: 10.1083/jcb.106.2.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Proença R., Carvalho M., Proença D., Verissimo J., Regadas I., Travassos A. HLA antigens and lymphocytes in proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1994 Jan;232(1):25–32. doi: 10.1007/BF00176434. [DOI] [PubMed] [Google Scholar]
  109. Rachal W. F., Burton T. C. Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol. 1979 Mar;97(3):480–483. doi: 10.1001/archopht.1979.01020010230008. [DOI] [PubMed] [Google Scholar]
  110. Robbins S. G., Mixon R. N., Wilson D. J., Hart C. E., Robertson J. E., Westra I., Planck S. R., Rosenbaum J. T. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci. 1994 Sep;35(10):3649–3663. [PubMed] [Google Scholar]
  111. Rodrigues M. M., Newsome D. A., Machemer R. Further characterization of epiretinal membranes in human massive periretinal proliferation. Curr Eye Res. 1981;1(6):311–315. doi: 10.3109/02713688108998357. [DOI] [PubMed] [Google Scholar]
  112. Rubsamen P. E., Davis P. A., Hernandez E., O'Grady G. E., Cousins S. W. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil. Arch Ophthalmol. 1994 Mar;112(3):407–413. doi: 10.1001/archopht.1994.01090150137036. [DOI] [PubMed] [Google Scholar]
  113. Scheiffarth O. F., Kampik A., Günther H., von der Mark K. Proteins of the extracellular matrix in vitreoretinal membranes. Graefes Arch Clin Exp Ophthalmol. 1988;226(4):357–361. doi: 10.1007/BF02172967. [DOI] [PubMed] [Google Scholar]
  114. Schwartz D., de la Cruz Z. C., Green W. R., Michels R. G. Proliferative vitreoretinopathy. Ultrastructural study of 20 retroretinal membranes removed by vitreous surgery. Retina. 1988;8(4):275–281. [PubMed] [Google Scholar]
  115. Scott S., Pandolfi F., Kurnick J. T. Fibroblasts mediate T cell survival: a proposed mechanism for retention of primed T cells. J Exp Med. 1990 Dec 1;172(6):1873–1876. doi: 10.1084/jem.172.6.1873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Smiddy W. E., Glaser B. M., Michels R. G., de Bustros S. Scleral buckle revision to treat recurrent rhegmatogenous retinal detachment. Ophthalmic Surg. 1990 Oct;21(10):716–720. [PubMed] [Google Scholar]
  117. Stanford M. R., Chignell A. H. Surgical treatment of superior bullous rhegmatogenous retinal detachments. Br J Ophthalmol. 1985 Oct;69(10):729–732. doi: 10.1136/bjo.69.10.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Stern W. H., Guerin C. J., Erickson P. A., Lewis G. P., Anderson D. H., Fisher S. K. Ocular toxicity of fluorouracil after vitrectomy. Am J Ophthalmol. 1983 Jul;96(1):43–51. doi: 10.1016/0002-9394(83)90453-1. [DOI] [PubMed] [Google Scholar]
  119. Stern W. H., Lewis G. P., Erickson P. A., Guerin C. J., Anderson D. H., Fisher S. K., O'Donnell J. J. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol. 1983 Jul;96(1):33–42. doi: 10.1016/0002-9394(83)90452-x. [DOI] [PubMed] [Google Scholar]
  120. Sternberg P., Jr, Machemer R. Subretinal proliferation. Am J Ophthalmol. 1984 Oct 15;98(4):456–462. doi: 10.1016/0002-9394(84)90131-4. [DOI] [PubMed] [Google Scholar]
  121. Tani P., Robertson D. M., Langworthy A. Prognosis for central vision and anatomic reattachment in rhegmatogenous retinal detachment with macula detached. Am J Ophthalmol. 1981 Nov;92(5):611–620. doi: 10.1016/s0002-9394(14)74651-3. [DOI] [PubMed] [Google Scholar]
  122. Tani P., Robertson D. M., Langworthy A. Rhegmatogenous retinal detachment without macular involvement treated with scleral buckling. Am J Ophthalmol. 1980 Oct;90(4):503–508. doi: 10.1016/s0002-9394(14)75019-6. [DOI] [PubMed] [Google Scholar]
  123. Tano Y., Chandler D., Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 1980 Dec;90(6):810–816. doi: 10.1016/s0002-9394(14)75196-7. [DOI] [PubMed] [Google Scholar]
  124. Tano Y., Sugita G., Abrams G., Machemer R. Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol. 1980 Jan;89(1):131–136. doi: 10.1016/0002-9394(80)90239-1. [DOI] [PubMed] [Google Scholar]
  125. Tornambe P. E., Hilton G. F., Kelly N. F., Salzano T. C., Wells J. W., Wendel R. T. Expanded indications for pneumatic retinopexy. Ophthalmology. 1988 May;95(5):597–600. doi: 10.1016/s0161-6420(88)33135-0. [DOI] [PubMed] [Google Scholar]
  126. Trese M. T., Chandler D. B., Machemer R. Subretinal strands: ultrastructural features. Graefes Arch Clin Exp Ophthalmol. 1985;223(1):35–40. doi: 10.1007/BF02150571. [DOI] [PubMed] [Google Scholar]
  127. Van Horn D. L., Aaberg T. M., Machemer R., Fenzl R. Glial cell proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1977 Sep;84(3):383–393. doi: 10.1016/0002-9394(77)90684-5. [DOI] [PubMed] [Google Scholar]
  128. Vidaurri-Leal J. S., Glaser B. M. Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol. 1984 Sep;102(9):1376–1379. doi: 10.1001/archopht.1984.01040031118037. [DOI] [PubMed] [Google Scholar]
  129. Vinores S. A., Campochiaro P. A., McGehee R., Orman W., Hackett S. F., Hjelmeland L. M. Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci. 1990 Dec;31(12):2529–2545. [PubMed] [Google Scholar]
  130. Vinores S. A., Van Niel E., Kim H. J., Campochiaro P. A. Simultaneous expression of keratin and glial fibrillary acidic protein by the same cells in epiretinal membranes. Invest Ophthalmol Vis Sci. 1992 Nov;33(12):3361–3366. [PubMed] [Google Scholar]
  131. Vrabec T. R., Reber R. N., Magargal L. E., Donoso L. A. S-antigen. Identification of human T-cell lymphocyte proliferation sites. Arch Ophthalmol. 1990 Oct;108(10):1470–1473. doi: 10.1001/archopht.1990.01070120118040. [DOI] [PubMed] [Google Scholar]
  132. Walshe R., Esser P., Wiedemann P., Heimann K. Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol. 1992 Sep;76(9):550–552. doi: 10.1136/bjo.76.9.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Weller M., Wiedemann P., Moter H., Heimann K. Transferrin and transferrin receptor expression in intraocular proliferative disease. APAAP-immunolabeling of retinal membranes and ELISA for vitreal transferrin. Graefes Arch Clin Exp Ophthalmol. 1989;227(3):281–286. doi: 10.1007/BF02172763. [DOI] [PubMed] [Google Scholar]
  134. Wiedemann P., Leinung C., Hilgers R. D., Heimann K. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1991;229(2):150–152. doi: 10.1007/BF00170548. [DOI] [PubMed] [Google Scholar]
  135. Wiedemann P., Lemmen K., Schmiedl R., Heimann K. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol. 1987 Jul 15;104(1):10–14. doi: 10.1016/0002-9394(87)90286-8. [DOI] [PubMed] [Google Scholar]
  136. Wilkes S. R., Mansour A. M., Green W. R. Proliferative vitreoretinopathy. Histopathology of retroretinal membranes. Retina. 1987 Summer;7(2):94–101. [PubMed] [Google Scholar]
  137. Williams D. F., Burke J. M. Modulation of growth in retina-derived cells by extracellular matrices. Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1717–1723. [PubMed] [Google Scholar]
  138. Williams G. A., Lambrou F. H., Jaffe G. A., Snyder R. W., Green G. D., Devenyi R. G., Abrams G. W. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator. Arch Ophthalmol. 1988 Aug;106(8):1055–1058. doi: 10.1001/archopht.1988.01060140211025. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES